Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00040657) titled 'Prospective Multicenter Observational Study on the Dynamics of Clonal Hematopoiesis (CHIP) in Patients with Multiple Myeloma Following Cilta-cel CAR T-Cell Therapy' on Sept. 10.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: prevention
Primary Sponsor: Klinikum Oldenburg AoR / Carl von Ossietzky Universitat Oldenburg
Condition:
C90.0
Multiple myeloma
Intervention:
Group 1: Adult patients with relapsed/refractory multiple myeloma who are scheduled to receive CAR T-cell therapy with ciltacabtagene autoleucel (cilta-cel).
Recruitment Status: Recruiting
...